Xenon Pharmaceuticals (XENE) EBITDA Margin Growth (5y) (2019 - 2025)
Xenon Pharmaceuticals (XENE) EBITDA Margin Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -85,635.00 |
| Sep 30, 2022 | -2.56 Mn |
| Jun 30, 2022 | 4.70 Mn |
| Mar 31, 2022 | 4.97 Mn |
| Dec 31, 2021 | 78,801.00 |
| Sep 30, 2021 | 158,306.00 |
| Jun 30, 2021 | 52,707.00 |
| Mar 31, 2021 | 57,294.00 |
| Dec 31, 2020 | -17,027.00 |
| Sep 30, 2020 | -12,889.00 |
| Jun 30, 2020 | -975.00 |
| Mar 31, 2020 | 3,955.00 |
| Dec 31, 2019 | -34,911.00 |
| Sep 30, 2019 | -32,139.00 |